NEWS
Our Latest News
ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing
SeqCenter is a category leader in Next-Generation Sequencing, which can sequence hundreds of thousands of genes in record-time and at low cost.
Global private equity healthcare specialist ARCHIMED announces the acquisition of Pittsburgh, Pennsylvania-based genetic sequencing provider SeqCenter. SeqCenter’s founding scientists initially worked at the University of Pittsburgh. Frustrated with the pace, cost and difficulty of obtaining sequencing data from existing vendors and academic core laboratories, they developed their own approach to gene sequencing, ultimately leaving academia and founding SeqCenter in 2019.
ARCHIMED récolte 315 M€ pour son 2ème véhicule
September
18,
2017
ARCHIMED atteint le hard cap pour son fonds II
September
18,
2017
Primo sponsors the Executive Master in Management specialized in Healthcare Business
December
9,
2016
En quête d’entreprises profitables
November
14,
2016
ARCHIMED buys four companies; HIS, Fytexia, Polyplus, and Micromed
September
20,
2016
368